Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock.
Eli Lilly’s new diabetes drug continues to show promise as an obesity treatment
Eli Lilly continues to work on commercializing its strong innovation pipeline, which is a key reason the CNBC Investing Club owns the stock.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender